Skip to content
Menu

Medpace Holdings, Inc. MEDP

Full chart Compare
Set alert

Price alert · MEDP

All alert types
646.83 USD -1.38 (-0.21%)

As ofNov 17, 2026, 3:01 PM EST

639.21 Day range 649.47
373.00 52-week range 693.97
YTD
+15.17%
1 year
+10.42%
Market cap
18.09B
Revenue (ttm)
2.84B
Profit margin
18.24%
EPS (ttm)
18.01
Shares out
27.97M
P/E ratio
35.91
Forward P/E
32.65
YTD return
+15.17%
1-year return
+10.42%
Volume
91.02K
Avg volume
257.56K
Open
646.19
Previous close
648.20
Day's range
639.21 – 649.47
52-week range
373.00 – 693.97
Beta
1.11
Price target
651.31 (+0.7%)
Earnings date
Feb 8, 2027

5D -23.38 (-3.49%)

650660670WedThuFriMonTue646.19

Key statistics

50-day average
629.52
200-day average
532.01
Enterprise value
17.76B
PEG ratio
3.36
Price / sales
6.39
Price / book
30.99
Revenue growth
8.50%
Free cash flow
497.78M
Total cash
705.32M
Total debt
171.46M
Return on equity
117.88%
Short % of float
6.17%

Fundamental scorecard

14 of 25 checks passed on MEDP’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 0 of 5
  • Growth 5 of 5
  • Profitability 5 of 5
  • Financial health 4 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
MEDP Revenue — quarterly 716.00M
MEDP Net income — quarterly 137.46M
MEDP EPS — quarterly 4.92

Earnings

MEDP recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 8, 2027Dec 30, 20264.82———
Oct 21, 2026Sep 30, 20264.444.84+0.40+9.01%
Jul 22, 2026Jun 30, 20263.984.25+0.27+6.78%
Apr 22, 2026Mar 31, 20263.924.28+0.36+9.18%
Feb 9, 2026Dec 31, 20254.194.67+0.48+11.46%
Oct 22, 2025Sep 30, 20253.533.86+0.33+9.35%

Upgrades / downgrades

MEDP analyst upgrades and downgrades
DateFirmActionFromTo
Oct 26, 2026BMO CapitalmainMarket PerformMarket Perform
Oct 23, 2026UBSmainNeutralNeutral
Oct 23, 2026Truist SecuritiesmainHoldHold
Oct 23, 2026BarclaysmainEqual-WeightEqual-Weight
Oct 23, 2026TD CowenmainHoldHold
Oct 7, 2026MizuhomainOutperformOutperform

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
medpace.com

News

Your note

Sign in to keep a note on MEDP — it syncs with the Stock Master app.

Insider holders

MEDP insider holders
InsiderRelationLatest transactionDateShares held
BRADY KEVIN M.Chief Financial OfficerSaleAug 19, 202612,830
BURWIG SUSAN ELIZABETHOfficerSaleOct 26, 202654,012
CARLEY BRIAN TDirectorSaleAug 18, 202627,825
DAVENPORT FRED B JRDirectorSaleAug 18, 20265,798
EWALD STEPHEN PGeneral CounselSaleOct 28, 202619,098
GEIGER JESSE JPresidentSaleMar 16, 202615,000

Institution ownership

MEDP institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.16%2,562,9371.66BSep 29, 2026
Price (T.Rowe) Associates Inc7.40%2,069,6771.34BJun 29, 2026
AQR Capital Management, LLC4.57%1,278,935829.01MJun 29, 2026
Vanguard Portfolio Management LLC3.88%1,085,294703.49MSep 29, 2026
Vanguard Capital Management LLC3.60%1,005,976652.07MSep 29, 2026
Geode Capital Management, LLC2.55%712,423461.79MSep 29, 2026

Fund ownership

MEDP fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF2.88%805,328522.01MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.59%724,942469.91MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.87%523,659339.44MJun 29, 2026
T. Rowe Price Equity Funds, Inc.-T. Rowe Price Large-Cap Growth Fund1.35%376,363243.96MJun 29, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Quality ETF1.18%329,256213.42MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.08%302,065195.80MJun 29, 2026